LFCR Lifecore Biomedical PE ratio, current and historical analysis

The current PE ratio of LFCR cannot be calculated, as the latest EPS of -$1.48 is negative. Lifecore Biomedical's last PE ratio on record was 27.27 in August 2024.

LFCR PE ratio history

How has LFCR's PE ratio performed in the past

The mean historical PE ratio of Lifecore Biomedical over the last ten years is 88.37. Looking back at the last ten years, LFCR's PE ratio peaked in the May 2019 quarter at 942, with a price of $9.42 and an EPS of $0.01. The May 2024 quarter marked the lowest point at 14.05, with a price of $5.62 and an EPS of $0.4.

Today
N/A
Average
88.37
Median
26.79
Minimum
14.05
Maximum
942

Lifecore Biomedical PE ratio by year

Maximum annual increase: 5,934.59% in 2019

Maximum annual decrease: -62.88% in 2012

Year PE ratio PE change Price EPS
2024 14.05 N/A $5.62 $0.4
2023 N/A N/A $7.94 -$3.32
2022 N/A N/A $9.87 -$3.97
2021 N/A N/A $11.97 -$1.1
2020 N/A N/A $10.67 -$1.31
2019 942 5,934.59% $9.42 $0.01
2018 15.61 -55.4% $14.05 $0.9
2017 35 N/A $13.65 $0.39
2016 N/A N/A $11.46 -$0.43
2015 28.58 71.34% $14.29 $0.5
2014 16.68 4.58% $12.01 $0.72
2013 15.95 10.53% $13.88 $0.87
2012 14.43 -62.88% $7.07 $0.49
2011 38.87 -5.82% $5.83 $0.15
2010 41.27 82.61% $6.19 $0.15

Lifecore Biomedical PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Feb 2025 N/A N/A $5.61 -$1.48
Nov 2024 N/A N/A $7.31 -$0.5
Aug 2024 27.27 94.09% $6 $0.22
May 2024 14.05 N/A $5.62 $0.4
Feb 2024 N/A N/A $8.07 -$0.67
Nov 2023 N/A N/A $7.51 -$2.38
Aug 2023 N/A N/A $8.39 -$3.28
May 2023 N/A N/A $7.94 -$3.32
Feb 2023 N/A N/A $5.85 -$3.9
Nov 2022 N/A N/A $8.37 -$3.15
Aug 2022 N/A N/A $10.19 -$4.02
May 2022 N/A N/A $9.87 -$3.97
Feb 2022 N/A N/A $11.54 -$2.87
Nov 2021 N/A N/A $8.67 -$2.47
Aug 2021 N/A N/A $10.87 -$1.62

LFCR average PE ratio chart

What is the average PE ratio of LFCR for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
88.37
15-year avg
51.51

LFCR PE vs peers

What is LFCR's PE ratio compared to its peers
Stock name PE ratio Market cap
OPTN OptiNose Inc N/A $91.66M
OPK Opko Health Inc N/A $1.04B
ORGO Organogenesis Holdings Inc N/A $490.82M
LFCR Lifecore Biomedical Inc N/A $195.86M

Frequently asked questions

What is Lifecore Biomedical's PE ratio?

The current price to earnings ratio of LFCR cannot be determined, as its EPS of -$1.48 is negative.

What is the highest PE ratio for LFCR?

The highest quarterly PE ratio in the last ten years has been 942 and it was in the May 2019 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.